This inventor holds 2 USPTO granted patents. Top assignee: National Science Council. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Shwu-Chen Tsay: Innovator in Antiviral Research
Introduction
Shwu-Chen Tsay is a prominent inventor based in Hsinchu, Taiwan. He has made significant contributions to the field of antiviral research, particularly in the development of novel compounds that target various viruses.
Latest Patents
Tsay holds 2 patents that focus on thymidylate and adenylate analogs. His first patent, titled "Thymidylate analogs and the use thereof," involves the synthesis of novel thymidylate analogs that are effective against human immunodeficiency virus type 1 (HIV-1). The compounds feature specific structural formulas that enhance their antiviral activity. The second patent, "Adenylate analogs as potent anti-herpes virus agents," describes adenylate analogs that show efficacy against herpes simplex viruses, utilizing unique chemical structures to achieve their therapeutic effects.
Career Highlights
Shwu-Chen Tsay is affiliated with the National Science Council, where he conducts research and development in the field of virology. His work has been instrumental in advancing the understanding of antiviral agents and their mechanisms of action.
Collaborations
Tsay has collaborated with notable colleagues, including Jih Ru Hwu and Gholam H Hakimelahi, to further enhance the impact of his research in the scientific community.
Conclusion
Shwu-Chen Tsay's innovative work in antiviral research has led to the development of promising therapeutic agents, showcasing his dedication to improving public health through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile